104 related articles for article (PubMed ID: 2474083)
1. [Clinical evaluation of serum basic fetoprotein--comparative study of serum immunosuppressive acid protein].
Gohji K; Arakawa S; Matsumoto O; Kamidono S; Oshima H; Nagata H; Iwamoto T; Hirooka K; Shimatani N; Inoue T
Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):711-8. PubMed ID: 2474083
[TBL] [Abstract][Full Text] [Related]
2. Serum basic fetoprotein in patients with renal cell carcinoma.
Gohji K; Ishii M; Nagata H; Matsumoto O; Kamidono S
Cancer; 1990 Mar; 65(6):1405-11. PubMed ID: 1689608
[TBL] [Abstract][Full Text] [Related]
3. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
[TBL] [Abstract][Full Text] [Related]
4. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
Hoshino M; Fuji K; Kataoka K; Inoue K; Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Oct; 35(10):1647-52. PubMed ID: 2610170
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
[TBL] [Abstract][Full Text] [Related]
6. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
Miyata Y; Koga S; Nishikido M; Noguchi M; Kanda S; Hayashi T; Saito Y; Kanetake H
Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: comparison with other tumour markers.
Masuda H; Kurita Y; Suzuki K; Fujita K; Aso Y
Br J Urol; 1997 Jul; 80(1):25-9. PubMed ID: 9240175
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of serum basic fetoprotein for prostatic cancer--comparative study with PAP, gamma-Sm and PSA].
Gotoh A; Mizuno Y; Takenaka A; Gohji K; Ogawa T; Arakawa S; Kamidono S; Harada K; Nagata H; Hirooka K
Nihon Hinyokika Gakkai Zasshi; 1991 Mar; 82(3):467-72. PubMed ID: 1712873
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
Sato T; Sakata Y; Tamura K
Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
[TBL] [Abstract][Full Text] [Related]
10. Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
Sasagawa I; Nakada T; Kubota Y; Suzuki H; Sawamura T
Br J Urol; 1994 Apr; 73(4):355-7. PubMed ID: 8199820
[TBL] [Abstract][Full Text] [Related]
11. Serum immunosuppressive acid protein predicts lymph node metastases in patients with renal cell carcinoma.
Pummer K; Pürstner P; Auner HL; Stettner H; Trummer H; Penkoff H; Rauchenwald M
Br J Urol; 1994 Jun; 73(6):612-4. PubMed ID: 8032825
[TBL] [Abstract][Full Text] [Related]
12. [Qualitative and quantitative parameters for prognosis in renal carcinoma in early and advanced stages].
Del Vecchio MT; Spina D; Lazzi S; Bruni A; Funtò I; Mattei FM; Fornaini M; Luzi P; Tosi P
Pathologica; 1997 Aug; 89(4):390-6. PubMed ID: 9471607
[TBL] [Abstract][Full Text] [Related]
13. Serum immunosuppressive acidic protein in renal cell carcinoma.
Ueda T
Urol Res; 1986; 14(2):101-3. PubMed ID: 3727211
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of serum S100ao protein in patients with renal cell carcinoma].
Morita T; Kikuchi T; Hashimoto S; Goto K; Tozuka K; Tokue A; Kato K; Kimura S
Nihon Hinyokika Gakkai Zasshi; 1990 Aug; 81(8):1162-7. PubMed ID: 2232407
[TBL] [Abstract][Full Text] [Related]
15. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological characteristics of small size renal cell carcinoma].
Onishi T; Ohishi Y; Iizuka N; Suzuki Y; Hatano T; Makino H; Tomita M
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):660-6. PubMed ID: 8709442
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of serum basic fetoprotein in patients with urogenital malignancies and renal transplantation].
Seguchi T; Sugao H; Takahara S; Nakano E; Ishibashi M; Sonoda T
Hinyokika Kiyo; 1991 Nov; 37(11):1475-9. PubMed ID: 1722636
[TBL] [Abstract][Full Text] [Related]
18. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
[TBL] [Abstract][Full Text] [Related]
19. Serum immunosuppressive acidic protein as a potent prognostic factor for patients with metastatic renal cell carcinoma.
Igarashi T; Tobe T; Kuramochi H; Akakura K; Ichikawa T; Hamano S; Suzuki N; Furuya Y; Ito H
Jpn J Clin Oncol; 2001 Jan; 31(1):13-7. PubMed ID: 11256835
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical and pathological characteristics in incidentally detected and suspected renal carcinoma.
Ueda T; Yasumasu T; Uozumi J; Naito S
Br J Urol; 1991 Nov; 68(5):470-2. PubMed ID: 1747720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
